• About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions
Red Liberty Press
  • Business
  • World
  • Science
  • Investing
No Result
View All Result
  • Business
  • World
  • Science
  • Investing
No Result
View All Result
Red Liberty Press
No Result
View All Result
Home World

China suggests Covid-19 originated in US in response to Trump allegation

May 1, 2025
in World
China suggests Covid-19 originated in US in response to Trump allegation
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

China restated its case that Covid-19 may have originated in the United States in a white paper on its pandemic response released on Wednesday, after President Donald Trump’s administration blamed a lab leak in China.

The White House launched a Covid-19 website on April 18 in which it said the coronavirus came from a lab leak in China while criticizing former President Joe Biden, former top US health official Anthony Fauci and the World Health Organization (WHO).

In the white paper, released by the official Xinhua news agency, China accused the US of politicizing the matter of the origins of Covid-19. It cited a Missouri lawsuit which resulted in a $24 billion ruling against China for hoarding protective medical equipment and covering up the outbreak.

China shared relevant information with the WHO and the international community in a timely manner, the white paper said, emphasizing that a joint study by the WHO and China had concluded that a lab leak was “extremely unlikely.”

The US should not continue to “pretend to be deaf and dumb,” but should respond to the legitimate concerns of the international community, the white paper said.

“Substantial evidence suggested the Covid-19 might have emerged in the United States earlier than its officially-claimed timeline, and earlier than the outbreak in China,” it said.

The CIA said in January the pandemic was more likely to have emerged from a lab in China than from nature, after the agency had for years said it could not reach a conclusion on the matter. It said it had “low confidence” in its new assessment and noted that both lab origin and natural origin remain plausible.

An official at China’s National Health Commission said the next step in origin-tracing work should focus on the US, according to Xinhua, which cited a statement about the white paper.

This post appeared first on cnn.com

Previous Post

US and Ukraine sign critical minerals deal after months of tense negotiations

Next Post

Israel conducts rare strike outside Damascus amid sectarian tensions in Syria

Next Post
Israel conducts rare strike outside Damascus amid sectarian tensions in Syria

Israel conducts rare strike outside Damascus amid sectarian tensions in Syria

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    Legendary Brazilian photographer Sebastião Salgado dead at 81

    Legendary Brazilian photographer Sebastião Salgado dead at 81

    May 24, 2025
    At least 12 injured in hot air balloon crash in Mexico

    At least 12 injured in hot air balloon crash in Mexico

    May 24, 2025
    Several people sustain ‘life-threatening’ injuries in knife attack at Hamburg’s Central Station, police say

    Several people sustain ‘life-threatening’ injuries in knife attack at Hamburg’s Central Station, police say

    May 24, 2025
    ‘What was that bang?’ Footage captures sound of Titan sub’s implosion

    ‘What was that bang?’ Footage captures sound of Titan sub’s implosion

    May 24, 2025

    Disclaimer: redlibertypress.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2024 redlibertypress.com | All Rights Reserved

    No Result
    View All Result
    • Business
    • World
    • Science
    • Investing

    Copyright © 2024 redlibertypress.com | All Rights Reserved